{
    "Symbol": "CTLT",
    "AssetType": "Common Stock",
    "Name": "Catalent Inc",
    "Description": "Catalent, Inc. (Catalent Pharma Solutions) is a multinational corporation headquartered in Somerset, New Jersey. It is a global provider of delivery technologies, development, drug manufacturing, biologics, gene therapies and consumer health products.",
    "CIK": "1596783",
    "Exchange": "NYSE",
    "Currency": "USD",
    "Country": "USA",
    "Sector": "LIFE SCIENCES",
    "Industry": "PHARMACEUTICAL PREPARATIONS",
    "Address": "14 SCHOOLHOUSE ROAD, SOMERSET, NJ, US",
    "FiscalYearEnd": "June",
    "LatestQuarter": "2024-03-31",
    "MarketCapitalization": "10818984000",
    "EBITDA": "355000000",
    "PERatio": "None",
    "PEGRatio": "2.057",
    "BookValue": "19.96",
    "DividendPerShare": "None",
    "DividendYield": "None",
    "EPS": "-6.48",
    "RevenuePerShareTTM": "22.75",
    "ProfitMargin": "-0.284",
    "OperatingMarginTTM": "0.0056",
    "ReturnOnAssetsTTM": "-0.0071",
    "ReturnOnEquityTTM": "-0.283",
    "RevenueTTM": "4135000000",
    "GrossProfitTTM": "1040000000",
    "DilutedEPSTTM": "-6.48",
    "QuarterlyEarningsGrowthYOY": "-0.154",
    "QuarterlyRevenueGrowthYOY": "0.036",
    "AnalystTargetPrice": "58.3",
    "AnalystRatingStrongBuy": "1",
    "AnalystRatingBuy": "0",
    "AnalystRatingHold": "9",
    "AnalystRatingSell": "0",
    "AnalystRatingStrongSell": "0",
    "TrailingPE": "-",
    "ForwardPE": "37.88",
    "PriceToSalesRatioTTM": "2.483",
    "PriceToBookRatio": "2.76",
    "EVToRevenue": "3.651",
    "EVToEBITDA": "-19.84",
    "Beta": "1.161",
    "52WeekHigh": "60.2",
    "52WeekLow": "31.8",
    "50DayMovingAverage": "56.52",
    "200DayMovingAverage": "51.26",
    "SharesOutstanding": "180980000",
    "DividendDate": "None",
    "ExDividendDate": "None"
}